Florian Robin

Florian Robin

Auto-generated profile, based on publicly available information

Florian Robin

Department of Anesthesiology and Pain Medicine, Université de Montréal, Pavillon Roger-Gaudry, local S-712, 2900, boul. Édouard-Montpetit, Montreal, QC, H2X 0C1, Canada, 1 514 343-6466

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
JCJérome Carlier
Jérome Carlier
FRFlorian Robin
Florian Robin
NPNicolas PAGES
Nicolas PAGES
AQAlice Quinart
Alice Quinart
MRMaxim Roy
Maxim Roy
KNKarine Nouette-Gaulain
Karine Nouette-Gaulain

12 July 2021 in Anaesthesia
Verified
Journal Article
Open access
PDF file
FRF. Robin
F. Robin
NNN. Newman
N. Newman
SGS. Garneau
S. Garneau
MRM. Roy
M. Roy
Click on the article title to read more.

26 August 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FRFlorian Robin
Florian Robin
MRMaxim Roy
Maxim Roy
AKAlexandre Kuftedjian
Alexandre Kuftedjian
MDMarie-Eve Desrosiers
Marie-Eve Desrosiers
FLFrederic Lavoie
Frederic Lavoie
GPGuy Paré
Guy Paré
Background: The increasing prevalence of ambulatory surgeries has highlighted the need for effective postoperative follow-up. While telemedicine represents a promising option for perioperative support and postoperative monitoring, evidence of its actual benefits remains limited. Objective: This study aims to evaluate the medico-economic impact of a personalized telemedicine platform for postoperative follow-up in day-surgery patients in terms of cost-effectiveness and cost-utility. Methods: This single-blinded, 2-group randomized controlled trial was conducted at the Centre Hospitalier de l’Université de Montréal (CHUM) from August 2022 to September 2023. Adults undergoing elective day surgery were randomized into 2 groups: the intervention group, which received postoperative follow-up via the LeoMed telemedicine platform, and the control group, which received standard care. The intervention group used a personalized telehealth platform offering preoperative education, psychological support, and postoperative monitoring through daily follow-up forms sent to patients’ smartphones. Alerts generated by patient responses were reviewed by CHUM’s telehealth support unit. The primary outcome was unanticipated health care usage, including emergency visits, readmissions, and medical consultations within 30 days postprocedure. Secondary outcomes included gained quality-adjusted life years (QALYs), patient satisfaction, health care costs, and greenhouse gas emissions. Demographic and outcome data were summarized using descriptive statistics; categorical variables were reported as frequencies and percentages, and continuous variables as means with standard deviations. Between-group comparisons were conducted using appropriate statistical tests by the HEC Montréal health economics team, following an intention-to-treat approach. Results: Of 1411 patients screened, 1214 were randomized, with 436 in the intervention group and 445 in the control group analyzed. Compliance with the platform was high, with a mean compliance index of 0.89 in the intervention group. No significant differences in unanticipated health care usage were observed. The average cost of unplanned care was CAD $370 (US $275) in the control group versus CAD $323 (US $239) in the intervention group (P=.60). The intervention group demonstrated a statistically significant QALY gain at postoperative day 14 (0.002; P=.01), but the difference was no longer significant at day 30 (0.001; P=0.14). There were also no significant differences in GHG emissions between the groups, with the intervention group emitting an average of 0.870 kg CO₂-eq compared with 1.055 kg CO₂-eq in the control group (P=.52). However, patient satisfaction was significantly higher in the intervention group at both days 14 (P=.02) and 30 (P<.001). Conclusions: This trial demonstrates the potential of telemedicine platforms to enhance postoperative care in ambulatory surgery settings. While no significant reductions in health care usage were observed, the intervention improved QALYs and patient satisfaction, suggesting potential cost-utility benefits. Larger trials are needed to confirm these findings and explore the impact on long-term recovery and health care savings.

1 December 2020 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
FRFlorian Robin
Florian Robin
HCHugues De Courson
Hugues De Courson
MRMaxim Roy
Maxim Roy
JLJoffrey Lemeux
Joffrey Lemeux
PPPierre Philip
Pierre Philip
Karine Nouette-GaulainKarine Nouette-Gaulain
Karine Nouette-Gaulain

24 April 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
FRFlorian Robin
Florian Robin
MRMaxim Roy
Maxim Roy
AKAlexandre Kuftedjian
Alexandre Kuftedjian
LPLaurelie Perret
Laurelie Perret
FLFrédéric Lavoie
Frédéric Lavoie
GPGuy Pare
Guy Pare
Background: The number of elective outpatient surgeries in Canada has increased markedly in the last 10 years. However, unanticipated cancellations on the day of surgery and adverse postoperative events are frequent. Modern technologies have been shown to be of great help in the medical field in improving patient care. Thus, it is likely that dedicated technologies could also significantly improve surgical outpatients’ pathways. Therefore, the department of anesthesiology at the University of Montreal Medical Center, in collaboration with LeoMed, a telemedicine platform, has developed a telehealth solution to offer more efficient perioperative support and follow-up for patients undergoing ambulatory surgery. Objective: The objective is to evaluate the medicoeconomic benefit of a dedicated perioperative telehealth platform for patients undergoing day surgery. Our hypothesis is that this dedicated telecare solution will allow more efficient patient care, which will reduce all types of medical costs related to day surgery pathways. Methods: This study is a single-center, single-blinded, 2-group randomized controlled trial. One thousand patients aged over 18 years with internet access who are scheduled to undergo ambulatory surgery will be enrolled and randomized either to follow a perioperative path that includes a patient-tailored perioperative digital app via the LeoMed telecare platform for 1 month or to follow the standard of care, which does not offer personalized digital support. The primary outcome will be to evaluate the cost-effectiveness of the telecare platform, assessing direct costs from factors such as unanticipated cancellations on the day of surgery due to preoperative instructions not being followed, calls to the local health information line, calls to the provincial health information line, emergency department consultations, unplanned readmissions, or medical visits for problems related to the surgical procedure within the first 30 days after the intervention. The secondary outcome will be to evaluate cost utility using a questionnaire assessing quality-adjusted life years. A blinded independent research team will analyze outcomes. All data will be analyzed according to the intention-to-treat principle. A sample size of 500 subjects in each group was calculated to detect a 21% reduction in postoperative complications with a power of 90%. This study has been approved by the ethics board of Centre hospitalier de l’Université de Montréal (University of Montreal Health Centre). No employee of LeoMed was involved in the study conception, and none will be involved in either data collection or analysis. Results: Results of this trial will be useful to determine the economic benefit of a telecare platform specifically developed for surgical outpatient pathways. Conclusions: We believe that the deployment of a dedicated perioperative telehealth app will lead to better patient care and fewer postoperative complications, which will lower all types of costs related to surgical outpatient care. Trial Registration: ClinicalTrials.gov NCT04948632; https://ClinicalTrials.gov/ct2/show/NCT04948632 International Registered Report Identifier (IRRID): DERR1-10.2196/44006

1 March 2019 in Anesthésie & Réanimation
Verified
Journal Article
Closed access
FRFlorian Robin
Florian Robin
AOAlexandre Ouattara
Alexandre Ouattara
KNKarine Nouette-Gaulain
Karine Nouette-Gaulain